Accredited clinical laboratory and life sciences company

2017

Fiala O, Hosek P, Pesek M, Finek J, Racek J, Stehlik P, Sorejs O, Minarik M, Benesova L, Celer A, Nemcova I, Kucera R, Topolcan O.
Serum Concentration of Erlotinib and its Correlation with Outcome and Toxicity in Patients with Advanced-stage NSCLC.
Anticancer Res. 2017 Nov;37(11):6469-6476., PMID: 29061834.

Svatoň M, Pešek M, Baxa J, Mukenšnabl P, Benešová L, Minárik M.
Patient with Three EGFR Mutations - Gradual Development of Resistance to Previous Targeted Treatment.lin Onkol. 2017 Winter;31(1):53-58. doi: 10.14735/amko201853. Czech., PMID: 29488779.